tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:KUR Stock Latest News

Kura Oncology reports inducement grants under Nasdaq listing rule
The FlyKura Oncology reports inducement grants under Nasdaq listing rule
14d ago
KURA
Kura Oncology price target lowered to $29 from $30 at BofA
PremiumThe Fly
Kura Oncology price target lowered to $29 from $30 at BofA
17d ago
KURA
Kura Oncology Tightens Governance with Amended Bylaws
PremiumCompany Announcements
Kura Oncology Tightens Governance with Amended Bylaws
21d ago
8K
KURA
Kura Oncology price target lowered to $20 from $25 at Leerink
PremiumThe Fly
Kura Oncology price target lowered to $20 from $25 at Leerink
1M ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
2M ago
KURA
Kura Oncology’s Promising Clinical Data and Strategic Partnerships Justify Buy Rating
PremiumRatingsKura Oncology’s Promising Clinical Data and Strategic Partnerships Justify Buy Rating
2M ago
KURA
Positive Outlook for Kura Oncology Driven by Promising Clinical Trials and Strategic Advancements
Premium
Ratings
Positive Outlook for Kura Oncology Driven by Promising Clinical Trials and Strategic Advancements
2M ago
KURA
Kura Oncology, Kyowa Kirin report combination data for KOMZIFTI with ven/aza
Premium
The Fly
Kura Oncology, Kyowa Kirin report combination data for KOMZIFTI with ven/aza
2M ago
KURA
Kura Oncology Announces First U.S. Sale of KOMZIFTI
PremiumCompany Announcements
Kura Oncology Announces First U.S. Sale of KOMZIFTI
3M ago
8K
KURA
Kura Oncology completes first U.S. commercial sale of KOMZIFTI
PremiumThe Fly
Kura Oncology completes first U.S. commercial sale of KOMZIFTI
3M ago
KURA
Kura Oncology’s Growth Potential Boosted by KOMZIFTI’s NCCN Inclusion and Competitive Advantages
PremiumRatings
Kura Oncology’s Growth Potential Boosted by KOMZIFTI’s NCCN Inclusion and Competitive Advantages
3M ago
KURA
Positive Outlook on Kura Oncology: Komzii’s Approval and Safety Profile Drive Buy Rating
PremiumRatings
Positive Outlook on Kura Oncology: Komzii’s Approval and Safety Profile Drive Buy Rating
3M ago
KURA
Kura Oncology price target raised to $28 from $11 at Barclays
PremiumThe FlyKura Oncology price target raised to $28 from $11 at Barclays
3M ago
KURA
Kura Oncology price target raised to $30 from $29 at BofA
Premium
The Fly
Kura Oncology price target raised to $30 from $29 at BofA
3M ago
KURA
Kura Oncology price target raised to $38 from $36 at Wedbush
Premium
The Fly
Kura Oncology price target raised to $38 from $36 at Wedbush
3M ago
KURA
Kura Oncology price target raised to $16 from $14 at UBS
PremiumThe Fly
Kura Oncology price target raised to $16 from $14 at UBS
3M ago
KURA
Kura Oncology’s Strategic Positioning and FDA Approval of Komzii Boosts Buy Rating
PremiumRatings
Kura Oncology’s Strategic Positioning and FDA Approval of Komzii Boosts Buy Rating
3M ago
KURA
Kura Oncology Gains FDA Approval for KOMZIFTITM
PremiumCompany Announcements
Kura Oncology Gains FDA Approval for KOMZIFTITM
3M ago
8K
KURA
Kura Oncology trading resumes
PremiumThe Fly
Kura Oncology trading resumes
3M ago
KURA
Kura Oncology, Kyowa Kirin announce FDA approval of KOMZIFTI for AML
PremiumThe FlyKura Oncology, Kyowa Kirin announce FDA approval of KOMZIFTI for AML
3M ago
KURA
FDA announces approval of Kura’s Komzifti for AML
Premium
The Fly
FDA announces approval of Kura’s Komzifti for AML
3M ago
KURA
Kura Oncology trading halted, news pending
Premium
The Fly
Kura Oncology trading halted, news pending
3M ago
KURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >